Samsung Biologics Strike Continues for Fifth Day Amid Stalled Talks
The strike by unionized workers at Samsung Biologics has entered its fifth day, with negotiations to resolve the industrial action reportedly stalled. The company estimates losses exceeding $100 million due to the ongoing walkout, as workers demand higher wages and expanded performance-based compensation.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)Sources
Samsung Biologics' strike enters 5th day
Unionized workers at Samsung Biologics Co., the biotech arm of Samsung Group, continued their first general strike for a fifth day Tuesday, demanding higher wages and expanded performance-based compensation. The walkout began Friday, with about 2,800 members out of the union's 4,000 members taking part, according to the union. It marks the first strike since the company's establishment in 2011. After wrapping up the five-day strike, the union plans to shift to a work-to-rule campaign Wednesday.
By The Korea Herald
Read full article →Samsung Biologics estimates strike has cost more than $100m
South Korean contract drug manufacturer Samsung Biologics estimated a strike by its labour union over pay that started late last month has cost the company about 150 billion won ($101.90 million).
By Abubakar Ibrahim
Read full article →Coverage Timeline
Related Stories
Chevron Announces $7 Billion Investment to Double Oil Production in Venezuela
17m ago
Global stocks fall as US-Iran tensions spike oil and bond yields
30m ago
Apple Names John Ternus as New CEO Following Tim Cook’s Departure
35m ago
Ryanair Cuts Winter Flights and Warns of Fare Hikes Amid Soaring Fuel Costs
47m ago